City Medical of Upper East Side, PLLC – Trademark Portfolio

Entity Type: 99

City Medical of Upper East Side, PLLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include CITYMD. The owner is based in New York, NY.

336 East 86th St

New York, NY 10028

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CITYMD
CITYMD
Registered 2011
CITYPEDS
CITYPEDS
Abandoned 2011
CITYMD
CITYMD
Registered 2011

Trademark Classifications

City Medical of Upper East Side, PLLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (3 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does City Medical of Upper East Side, PLLC have?

City Medical of Upper East Side, PLLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does City Medical of Upper East Side, PLLC file in?

City Medical of Upper East Side, PLLC files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are City Medical of Upper East Side, PLLC's most well-known trademarks?

City Medical of Upper East Side, PLLC's registered trademark portfolio includes well-known marks such as CITYMD. These are among 2 currently registered trademarks in the portfolio.

What is City Medical of Upper East Side, PLLC's trademark registration success rate?

City Medical of Upper East Side, PLLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.